{"entity":{"type":"insider","cik":"0001814189","url":"/insider/0001814189","json_url":"/insider/0001814189.json","name":"Kerr Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":13,"first":"2021-01-13","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Kerr Douglas","source":"filing","n_filings":13,"first_seen":"2021-01-13","last_seen":"2026-08-17"}],"transactions":[{"id":9296076,"accession":"0001814189-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001814189-26-000004","line_url":"/filing/0001814189-26-000004#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1556.0,"shares_display":"1,556","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":40891.68,"total_display":"40,891.68","total_whole":"40,892","shares_owned_after":167599.0,"shares_owned_after_display":"167,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider"},{"id":5829409,"accession":"0001814189-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001814189-26-000002","line_url":"/filing/0001814189-26-000002#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":887.0,"shares_display":"887","price_per_share":18.33,"price_display":"18.33","price_state":"stated","total_value":16258.71,"total_display":"16,258.71","total_whole":"16,259","shares_owned_after":169155.0,"shares_owned_after_display":"169,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":6040344,"accession":"0001193125-26-223966","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-223966","line_url":"/filing/0001193125-26-223966#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1564.0,"shares_display":"1,564","price_per_share":18.36,"price_display":"18.36","price_state":"stated","total_value":28715.04,"total_display":"28,715.04","total_whole":"28,715","shares_owned_after":170042.0,"shares_owned_after_display":"170,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-14","scope":"insider"},{"id":6229297,"accession":"0001193125-26-096517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-096517","line_url":"/filing/0001193125-26-096517#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":904.0,"shares_display":"904","price_per_share":14.9,"price_display":"14.90","price_state":"stated","total_value":13469.6,"total_display":"13,469.60","total_whole":"13,470","shares_owned_after":171606.0,"shares_owned_after_display":"171,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":5183524,"accession":"0001193125-25-309641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-309641","line_url":"/filing/0001193125-25-309641#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":880.0,"shares_display":"880","price_per_share":20.72,"price_display":"20.72","price_state":"stated","total_value":18233.6,"total_display":"18,233.60","total_whole":"18,234","shares_owned_after":87510.0,"shares_owned_after_display":"87,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider"},{"id":4237205,"accession":"0000950170-25-113538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-113538","line_url":"/filing/0000950170-25-113538#line-2","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":873.0,"shares_display":"873","price_per_share":13.41,"price_display":"13.41","price_state":"stated","total_value":11706.93,"total_display":"11,706.93","total_whole":"11,707","shares_owned_after":88390.0,"shares_owned_after_display":"88,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":4237201,"accession":"0000950170-25-113538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113538","line_url":"/filing/0000950170-25-113538#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3552.0,"shares_display":"3,552","price_per_share":13.27,"price_display":"13.27","price_state":"stated","total_value":47135.04,"total_display":"47,135.04","total_whole":"47,135","shares_owned_after":89263.0,"shares_owned_after_display":"89,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":4946834,"accession":"0000950170-25-083048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-083048","line_url":"/filing/0000950170-25-083048#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1342.0,"shares_display":"1,342","price_per_share":13.35,"price_display":"13.35","price_state":"stated","total_value":17915.7,"total_display":"17,915.70","total_whole":"17,916","shares_owned_after":92815.0,"shares_owned_after_display":"92,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":4791129,"accession":"0000950170-25-035499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035499","line_url":"/filing/0000950170-25-035499#line-1","is_derivative":false,"issuer_cik":"0001814189","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001814189","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1343.0,"shares_display":"1,343","price_per_share":11.83,"price_display":"11.83","price_state":"stated","total_value":15887.69,"total_display":"15,887.69","total_whole":"15,888","shares_owned_after":94157.0,"shares_owned_after_display":"94,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":4446302,"accession":"0001415889-21-003583","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-21-003583","line_url":"/filing/0001415889-21-003583","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3518.0,"shares_display":"3,518","price_per_share":25.204781125639567,"price_display":"25.20","price_state":"stated","total_value":88670.42,"total_display":"88,670.42","total_whole":"88,670","shares_owned_after":326558.0,"shares_owned_after_display":"326,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-12","scope":"insider","n_lines":2},{"id":5125951,"accession":"0001415889-21-001930","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-21-001930","line_url":"/filing/0001415889-21-001930","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14072.0,"shares_display":"14,072","price_per_share":30.09172043774872,"price_display":"30.09","price_state":"stated","total_value":423450.69,"total_display":"423,450.69","total_whole":"423,451","shares_owned_after":329879.0,"shares_owned_after_display":"329,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider","n_lines":2},{"id":4544726,"accession":"0001415889-21-001382","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-21-001382","line_url":"/filing/0001415889-21-001382","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11267.0,"shares_display":"11,267","price_per_share":31.44290050590219,"price_display":"31.44","price_state":"stated","total_value":354267.16,"total_display":"354,267.16","total_whole":"354,267","shares_owned_after":328333.0,"shares_owned_after_display":"328,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider","n_lines":7},{"id":5180690,"accession":"0001415889-21-000623","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-21-000623","line_url":"/filing/0001415889-21-000623","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11267.0,"shares_display":"11,267","price_per_share":33.36774296618443,"price_display":"33.37","price_state":"stated","total_value":375954.36,"total_display":"375,954.36","total_whole":"375,954","shares_owned_after":330325.0,"shares_owned_after_display":"330,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider","n_lines":2},{"id":4926263,"accession":"0001415889-21-000313","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-21-000313","line_url":"/filing/0001415889-21-000313","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001814189","owner_name":"Kerr Douglas","owner_display_name":"Kerr Douglas","owner_url":"/insider/0001814189","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11267.0,"shares_display":"11,267","price_per_share":27.58213100204136,"price_display":"27.58","price_state":"stated","total_value":310767.87,"total_display":"310,767.87","total_whole":"310,768","shares_owned_after":331579.0,"shares_owned_after_display":"331,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Medical Officer)","n_filings":8,"first_seen":"2025-03-07","last_seen":"2026-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":5,"first_seen":"2021-01-13","last_seen":"2021-07-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001814189","retrieved_at":"2026-08-26T15:41:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}